Expression and amplification of cyclin genes in human breast cancer.Michael F. Buckley, R. Sutherland, Kimberley J. E. Sweeney et al.|PubMed|1993Cited by 676
Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.C. K. W. Watts, R. Sutherland, Ann L. Brady et al.|Molecular Endocrinology|1995Cited by 179
Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos.M. Händel, R. Sutherland, C. K. W. Watts et al.|Proceedings of the National Academy of Sciences|1995Cited by 133
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitroPhilip O'Brien, R. L. Sutherland, Michael J. Davies et al.|British Journal of Cancer|2008Cited by 69
Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.Anna DeFazio, R. Sutherland, Yoke-Eng Chiew et al.|PubMed|1997Cited by 42